Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma (abst – 2006)http://www.ncbi.nlm.nih.gov/pubmed/16314952

Preclinical studies of KM-233, a safe and effective classical cannabinoid chemotherapeutic for the treatment of high-grade glioma (news – 2006) http://www.aans.org/Media/Article.aspx?ArticleId=36969

Synthesis of Novel Cannabinoid Ligands and Their Use as Anti-Glioma and Anti-Inflammatory Agents (full – 2010)http://etd.uthsc.edu/WORLD-ACCESS/Gu...030-Gurley.pdf

Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233 (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22875710